Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer
- 3 April 2009
- journal article
- Published by Elsevier in European Urology
- Vol. 56 (2) , 237-244
- https://doi.org/10.1016/j.eururo.2009.03.073
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Phase II Trial of Docetaxel With Rapid Androgen Cycling for Progressive Noncastrate Prostate CancerJournal of Clinical Oncology, 2008
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working GroupJournal of Clinical Oncology, 2008
- Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate CancerClinical Cancer Research, 2007
- Rapid Androgen Cycling as Treatment for Patients with Prostate CancerClinical Cancer Research, 2006
- Enhancement of intermittent androgen ablation by “off‐cycle” maintenance with finasteride in LNCaP prostate cancer xenograft modelThe Prostate, 2005
- Fluorodeoxyglucose Positron Emission Tomography as an Outcome Measure for Castrate Metastatic Prostate Cancer Treated with Antimicrotubule ChemotherapyClinical Cancer Research, 2005
- Studies on Prostatic Cancer: I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the ProstateJournal of Urology, 2002
- Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride.Proceedings of the National Academy of Sciences, 1996
- Androgen receptor gene amplification: A novel molecular mechanism for endocrine therapy resistance in human prostate cancerScandinavian Journal of Clinical and Laboratory Investigation, 1996
- Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaPThe Journal of Steroid Biochemistry and Molecular Biology, 1995